HASE treatment markedly up-regulated mRNA expression levels of CAT and GPX-1 and down-regulated mRNA expression levels of COX-2 and CHI3L1 as compared to the RA group (p < 0.05). This evidence concerns the gene GPX1 and rheumatoid arthritis.